Search All UT System Experts

Erratum: Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin (Diabetes Care (2003) 26 (2063-2068))

Philip Raskin, L. Klaff, J. McGill, S. A. South, P. Hollander, N. Khutoryansky, P. M. Hale

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin (Diabetes Care (2003) 26 (2063-2068))'. Together they form a unique fingerprint.